Loading
A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery is a phase 1 interventional study registered as NCT02496065 by Blaze Bioscience Inc., with 30 participants enrolled, started 2015-07. Conditions recorded: Tumors, Breast. Interventions recorded: BLZ-100.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/